keyword
https://read.qxmd.com/read/38728523/exploring-the-efficacy-and-molecular-mechanism-of-danhong-injection-comprehensively-in-the-treatment-of-idiopathic-pulmonary-fibrosis-by-combining-meta-analysis-network-pharmacology-and-molecular-docking-methods
#1
JOURNAL ARTICLE
Xiaozheng Wu, Wen Li, Zhenliang Luo, Yunzhi Chen
BACKGROUND: Danhong injection, a compound injection of Chinese herbal medicine, has been widely used in idiopathic pulmonary fibrosis (IPF) at present as an adjuvant treatment. However, the clinical efficacy and molecular mechanism of IPF are still unclear. This study will evaluate and explore the clinical efficacy and molecular mechanism of Danhong injection in the treatment of IPF. METHODS: In meta-analysis, the computer was used to search 8 databases (PubMed, EMbase, CENTRAL, MEDLINE, CBM, CNKI, WanFang, and VIP) to collect the RCTs, and RevMan 5...
May 10, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38725658/editorial-pathogen-targeting-in-chronic-respiratory-diseases-prevention-therapy-and-management
#2
EDITORIAL
Shakti D Shukla, Kamal Dua, Ronan F O'Toole
No abstract text is available yet for this article.
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38725147/supramolecular-nanofibers-ameliorate-bleomycin-induced-pulmonary-fibrosis-by-restoring-autophagy
#3
JOURNAL ARTICLE
Debin Zheng, Jiasen Guo, Ziyi Liang, Yueyue Jin, Yinghao Ding, Jingfei Liu, Chao Qi, Kaiwen Shi, Limin Xie, Meiqi Zhu, Ling Wang, Zhiwen Hu, Zhimou Yang, Qian Liu, Xiaoxue Li, Wen Ning, Jie Gao
Idiopathic pulmonary fibrosis (IPF) is a progressive and ultimately fatal interstitial lung disease, with limited therapeutic options available. Impaired autophagy resulting from aberrant TRB3/p62 protein-protein interactions (PPIs) contributes to the progression of IPF. Restoration of autophagy by modulating the TRB3/p62 PPIs has rarely been reported for the treatment of IPF. Herein, peptide nanofibers are developed that specifically bind to TRB3 protein and explored their potential as a therapeutic approach for IPF...
May 9, 2024: Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
https://read.qxmd.com/read/38723554/mda5-autoimmunity-and-interstitial-pneumonitis-contemporaneous-with-the-covid-19-pandemic-mip-c
#4
JOURNAL ARTICLE
Paula David, Saptarshi Sinha, Khizer Iqbal, Gabriele De Marco, Sahar Taheri, Ella McLaren, Sheetal Maisuria, Gururaj Arumugakani, Zoe Ash, Catrin Buckley, Lauren Coles, Chamila Hettiarachchi, Emma Payne, Sinisa Savic, Gayle Smithson, Maria Slade, Rahul Shah, Helena Marzo-Ortega, Mansoor Keen, Catherine Lawson, Joanna Mclorinan, Sharmin Nizam, Hanu Reddy, Omer Sharif, Shabina Sultan, Gui Tran, Mark Wood, Samuel Wood, Pradipta Ghosh, Dennis McGonagle
BACKGROUND: Anti-MDA5 (Melanoma differentiation-associated protein-5) positive dermatomyositis (MDA5+ -DM) is characterised by rapidly progressive interstitial lung disease (ILD) and high mortality. MDA5 is an RNA sensor and a key pattern recognition receptor for the SARS-CoV-2 virus. METHODS: This is a retrospective observational study of a surge in MDA5 autoimmunity, as determined using a 15 muscle-specific autoantibodies (MSAs) panel, between Janurary 2018 and December 2022 in Yorkshire, UK...
May 8, 2024: EBioMedicine
https://read.qxmd.com/read/38723442/squamous-metaplasia-is-an-indicator-of-acute-exacerbation-in-patients-with-usual-interstitial-pneumonia-idiopathic-pulmonary-fibrosis
#5
JOURNAL ARTICLE
Yuri Tachibana, Masatake Hara, Mikiko Hashisako, Yasuhiko Yamano, Kensuke Kataoka, Yasuhiro Kondoh, Takeshi Johkoh, Shimpei Morimoto, Andrey Bychkov, Junya Fukuoka
BACKGROUND: Acute exacerbation (AE) is a potentially lethal event in patients with usual interstitial pneumonia/idiopathic pulmonary fibrosis (UIP/IPF). However, to date, no pathological predictors of AE have been identified. This retrospective study aimed to elucidate the pathological features that could predict AE in patients with UIP. METHODS: We reviewed the pathological findings of 91 patients with UIP/IPF and correlated these findings with AE events. Thirteen histological variables related to acute lung injury were evaluated by three independent observers and classified as positive or negative...
May 8, 2024: Respiratory Investigation
https://read.qxmd.com/read/38721688/immature-platelet-fraction-as-a-systemic-inflammation-marker-in-patients-with-chronic-obstructive-pulmonary-disease
#6
JOURNAL ARTICLE
Nasser Absieh, Fatma Arslan, Özlem Doğan, Aslıhan Gürün Kaya, Miraç Öz, Serhat Erol, Aydın Çiledağ, Akın Kaya
INTRODUCTION: Recently, there has been an increasing interest to find a simple, low cost, widely available biomarker for outcome predictors in chronic obstructive pulmonary disease (COPD). METHODS: Absolute immature platelet count (AIPC), the percentage of AIPC to the total platelet count (immature platelet fraction [IPF%]), symptoms, spirometry results, age-dyspne-airflow obstruction index, and C-reactive protein tests of COPD patients and control group were recorded...
May 9, 2024: International Journal of Laboratory Hematology
https://read.qxmd.com/read/38720166/plausible-role-of-inpp4a-dysregulation-in-idiopathic-pulmonary-fibrosis
#7
JOURNAL ARTICLE
Meghana Arvind, Bijay Pattnaik, Atish Gheware, Y S Prakash, Mousami Srivastava, Anurag Agrawal, Naveen Kumar Bhatraju
INPP4A has been shown to be involved in the regulation of cell proliferation and apoptosis of multiple cell types including fibroblasts. Previous reports from our group have demonstrated the role of inositol polyphosphate 4-phosphatase Type I A (INPP4A) in these functions. Though existing evidences suggest a critical role for INPP4A in the maintenance of lung homeostasis, its role in chronic lung diseases is relatively under explored. In the current study, we made an attempt to understand the regulation of INPP4A in idiopathic pulmonary fibrosis (IPF)...
May 2024: Physiological Reports
https://read.qxmd.com/read/38717537/guardians-turned-culprits-netosis-and-its-influence-on-pulmonary-fibrosis-development
#8
REVIEW
Aleena Varughese, Akarsha Balnadupete, Poornima Ramesh, Thottethodi Subrahmanya Keshava Prasad, Ayshath Burhana Nidha, Yashodhar Bhandary
Idiopathic pulmonary fibrosis (IPF) is a debilitating, life-threatening irreversible lung disease characterized by the excessive accumulation of fibrotic tissue in the lungs, impairing their function. The exact mechanisms underlying Pulmonary fibrosis (PF) are multifaceted and not yet fully understood. Reports show that during COVID-19 pandemic, PF was dramatically increased due to the hyperactivation of the immune system. Neutrophils and macrophages are the patrolling immune cells that keep the microenvironment balanced...
May 8, 2024: Molecular Biotechnology
https://read.qxmd.com/read/38717532/microrna-26a-in-respiratory-diseases-mechanisms-and-therapeutic-potential
#9
REVIEW
Xiaoshan Liu, Qian Chen, Shuxia Jiang, Hongli Shan, Tong Yu
MicroRNAs (miRNAs) are short, non-coding single-stranded RNA molecules approximately 22 nucleotides in length, intricately involved in post-transcriptional gene expression regulation. Over recent years, researchers have focused keenly on miRNAs, delving into their mechanisms in various diseases such as cancers. Among these, miR-26a emerges as a pivotal player in respiratory ailments such as pneumonia, idiopathic pulmonary fibrosis, lung cancer, asthma, and chronic obstructive pulmonary disease. Studies have underscored the significance of miR-26a in the pathogenesis and progression of respiratory diseases, positioning it as a promising therapeutic target...
May 8, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38717443/single-cell-profiling-reveals-immune-aberrations-in-progressive-idiopathic-pulmonary-fibrosis
#10
JOURNAL ARTICLE
Avraham Unterman, Amy Y Zhao, Nir Neumark, Jonas C Schupp, Farida Ahangari, Carlos Cosme, Prapti Sharma, Jasper Flint, Yan Stein, Changwan Ryu, Genta Ishikawa, Tomokazu S Sumida, Jose L Gomez, Jose D Herazo-Maya, Charles S Dela Cruz, Erica L Herzog, Naftali Kaminski
RATIONALE: Changes in peripheral blood cell populations have been observed but not detailed at single-cell resolution in idiopathic pulmonary fibrosis (IPF). OBJECTIVES: To provide an atlas of the changes in the peripheral immune system in stable and progressive IPF. METHODS: Peripheral blood mononuclear cells (PBMCs) from IPF patients and controls were profiled using 10x Chromium 5' single-cell RNA sequencing (scRNA-seq). Flow cytometry was used for validation...
May 8, 2024: American Journal of Respiratory and Critical Care Medicine
https://read.qxmd.com/read/38716640/bilateral-orthotopic-lung-transplant-via-a-clamshell-thoracosternotomy-from-a-donor-with-extended-cold-static-lung-preservation
#11
Yuriy Stukov, Mindaugas Rackauskas
In this video tutorial, we present a comprehensive step-by-step operative technique for a bilateral orthotopic lung transplant using a bilateral transverse thoracosternotomy in a patient with idiopathic pulmonary fibrosis lung disease. The donor lungs were exposed to extended cold static ischaemic storage at 10° C for the semi-elective operation.
May 8, 2024: Multimedia Manual of Cardiothoracic Surgery: MMCTS
https://read.qxmd.com/read/38712072/pre-clinical-proof-of-concept-of-anti-fibrotic-activity-of-caveolin-1-scaffolding-domain-peptide-lti-03-in-ex-vivo-precision-cut-lung-slices-from-patients-with-idiopathic-pulmonary-fibrosis
#12
BreAnne MacKenzie, Poornima Mahavadi, Yago Amigo Pinho Jannini-Sa, Brecht Creyns, Ana Lucia Coelho, Milena Espindola, Clemens Ruppert, Konrad Hötzenecker, Cory Hogaboam, Andreas Guenther
Rationale: While rodent lung fibrosis models are routinely used to evaluate novel antifibrotics, these models have largely failed to predict clinical efficacy of novel drug candidates for Idiopathic Pulmonary Fibrosis (IPF). Moreover, single target therapeutic strategies for IPF have failed and current multi-target standard of care drugs are not curative. Caveolin-1 (CAV-1) is an integral membrane protein, which, via its caveolin scaffolding domain (CSD), interacts with caveolin binding domains (CBD). CAV-1 regulates homeostasis, and its expression is decreased in IPF lungs...
April 28, 2024: bioRxiv
https://read.qxmd.com/read/38708496/-shenqi-chongcao-formula-ameliorates-inflammatory-response-in-rats-with-pulmonary-fibrosis-by-activating-the-ass1-src-stat3-signaling-pathway
#13
JOURNAL ARTICLE
C He, W Chen, N Zhang, J Luan, S Wang, Y Zhang
OBJECTIVE: To observe the effect of Shenqi Chongcao (SQCC) Formula on the ASS1/src/STAT3 signaling pathway in a rat model of lung fibrosis and explore its therapeutic mechanism. METHODS: A total of 120 male SD rats were divided equally into 5 groups, including a blank control group with saline treatment and 4 groups of rat models of idiopathic pulmonary fibrosis induced by intratracheal instillation of bleomycin. One day after modeling, the rat models were treated with daily gavage of 10 mL/kg saline, SQCC decoction (0...
April 20, 2024: Nan Fang Yi Ke da Xue Xue Bao, Journal of Southern Medical University
https://read.qxmd.com/read/38704585/lipocalin-2-as-a-prognostic-marker-in-patients-with-acute-exacerbation-of-idiopathic-pulmonary-fibrosis
#14
JOURNAL ARTICLE
Hiroki Tanahashi, Hiroshi Iwamoto, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Taku Nakashima, Shinichiro Ohshimo, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori
BACKGROUND: Lipocalin-2 (LCN2) is a secretory glycoprotein upregulated by oxidative stress; moreover, patients with idiopathic pulmonary fibrosis (IPF) have shown increased LCN2 levels in bronchoalveolar lavage fluid (BALF). This study aimed to determine whether circulatory LCN2 could be a systemic biomarker in patients with IPF and to investigate the role of LCN2 in a bleomycin-induced lung injury mouse model. METHODS: We measured serum LCN2 levels in 99 patients with stable IPF, 27 patients with acute exacerbation (AE) of IPF, 51 patients with chronic hypersensitivity pneumonitis, and 67 healthy controls...
May 4, 2024: Respiratory Research
https://read.qxmd.com/read/38704309/issue-3-the-occupational-burden-of-respiratory-diseases-an-update
#15
REVIEW
N Murgia, M Akgun, P D Blanc, J T Costa, S Moitra, X Muñoz, K Toren, A J Ferreira
INTRODUCTION AND AIMS: Workplace exposures are widely known to cause specific occupational diseases such as silicosis and asbestosis, but they also can contribute substantially to causation of common respiratory diseases. In 2019, the American Thoracic Society (ATS) and the European Respiratory Society (ERS) published a joint statement on the occupational burden of respiratory diseases. Our aim on this narrative review is to summarise the most recent evidence published after the ATS/ERS statement as well as to provide information on traditional occupational lung diseases that can be useful for clinicians and researchers...
May 3, 2024: Pulmonology
https://read.qxmd.com/read/38703930/combination-of-co-amorphization-with-snedds-outperforms-ofev%C3%A2-in-the-oral-absorption-of-nintedanib
#16
JOURNAL ARTICLE
Tomoya Inoue, Seito Maehara, Masato Maruyama, Kazutaka Higaki
Nintedanib (NTD), approved for the treatment of idiopathic pulmonary fibrosis and advanced non-small cell lung cancer, is one of brick dusts with high melting point. Although NTD has been marketed as Ofev®, a soft capsule of NTD ethanesulfonate (NTD-ESA) suspended in oil components, the oral bioavailability is quite low and highly variable. To improve the oral absorption behavior of NTD, we prepared SNEDDS formulation containing NTD-(+)-10-camphorsulfonic acid (CSA) complex with 2 % HPMCP-50. CSA disrupted the high crystallinity of NTD-ESA and the formed complex, NTD-CSA, was found to be amorphous by DSC and XRPD...
May 2, 2024: International Journal of Pharmaceutics
https://read.qxmd.com/read/38703806/urea-cycle-promotion-via-ammonia-upregulated-cps1-is-involved-in-arsenite-induced-pulmonary-fibrosis-through-enhancing-collagen-synthesis
#17
JOURNAL ARTICLE
Daxiao Xie, Peiwen Wang, Weiyong Chen, Jiaheng Lin, Meng Wu, Yue Wang, Haibo Xia, Cheng Cheng, Fuping Ye, Binafsha Manzoor Syed, Qizhan Liu
Arsenic exposure is connected with lung toxicity and is related to lung fibrotic changes. Idiopathic pulmonary fibrosis (IPF) is characterized by extracellular matrix (ECM) deposition. Various genetic mechanisms and environmental factors induce or exacerbate pulmonary fibrosis. Collagen synthesis induced by arsenite (NaAsO2 ) is closely associated with IPF. Fibroblasts tend to fine-tune their metabolic networks to support their synthetic requirements in response to environmental stimuli. Alterations in metabolism have an influential role in the pathogenesis of IPF...
May 2, 2024: Chemico-biological Interactions
https://read.qxmd.com/read/38703565/shared-biomarkers-and-mechanisms-in-idiopathic-pulmonary-fibrosis-and-non-small-cell-lung-cancer
#18
JOURNAL ARTICLE
Xiaorui Ding, Huarui Liu, Qinghua Xu, Tong Ji, Ranxun Chen, Zhengcheng Liu, Jinghong Dai
BACKGROUND: Epidemiological evidence has indicated the occurrence of idiopathic pulmonary fibrosis (IPF) with coexisting lung cancer is not a coincidence. The pathogenic mechanisms shared between IPF and non-small cell lung cancer (NSCLC) at the transcriptional level remain elusive and need to be further elucidated. METHODS: IPF and NSCLC datasets of expression profiles were obtained from the GEO database. Firstly, to detect the shared dysregulated genes positively correlated with both IPF and NSCLC, differentially expressed analysis and WGCNA analysis were carried out...
May 3, 2024: International Immunopharmacology
https://read.qxmd.com/read/38702265/lung-transplantation-in-patients-with-systemic-scleroderma-description-of-the-first-consecutive-cases-in-poland-case-series-report-and-a-short-literature-review
#19
JOURNAL ARTICLE
Tomasz Stącel, Paweł Sybila, Agata Mędrala, Marek Ochman, Mirosław Nęcki, Piotr Pasek, Kamil Kegler, Piotr Przybyłowski, Tomasz Hrapkowicz, Dawid Borowik, Maciej Urlik
Pulmonary complications of systemic scleroderma (SSc), such as interstitial lung disease and pulmonary hypertension (PH), are responsible for up to 60% of deaths among patients. For many years, most centers considered SSc a contraindication to lung transplantation (LTx); however, recent publications show that appropriately selected SSc candidates for LTx give results comparable to patients with idiopathic PH or idiopathic pulmonary fibrosis. This paper presents the cases of a 60-year-old male patient (patient 1) and a 42-year-old female patient (patient 2) diagnosed with SSc in 2019 and 2013, respectively...
May 2, 2024: Transplantation Proceedings
https://read.qxmd.com/read/38701884/cell-selective-bcl-2-inhibition-enabled-by-lipid-nanoparticles-alleviates-lung-fibrosis
#20
JOURNAL ARTICLE
Rimpy Diwan, Himanshu N Bhatt, Rui Dong, Igor L Estevao, Armando Varela-Ramirez, Md Nurunnabi
Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease with a high mortality rate due to limited treatment options. Current therapies cannot effectively reverse the damage caused by IPF. Research suggests that promoting programmed cell death (apoptosis) in myofibroblasts, the key cells driving fibrosis, could be a promising strategy. However, inducing apoptosis in healthy cells like epithelial and endothelial cells can cause unwanted side effects. This project addresses this challenge by developing a targeted approach to induce apoptosis specifically in myofibroblasts...
May 1, 2024: Journal of Controlled Release
keyword
keyword
7070
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.